Oncological outcomes of transanal local excision for high risk T1 rectal cancers

doi:10.4251/wjgo.v4.i4.84

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 4

This Article

(0)

(4501)

(7)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Brief Article

World J Gastrointest Oncol. Apr 15, 2012; 4(4): 84-88
Published online Apr 15, 2012. doi: 10.4251/wjgo.v4.i4.84

Table 3 Histopathological characteristics of patients with tumor recurrence

Tumor differentiation	Margin status	Lymphovascular invasion	Group	Type of recurrence	Salvage therapy	Follow up (mo)	Remarks
Poor	Negative	Positive	A	Rectum lung	Chemoradiotherapy¹	52	Dead
Poor	Positive	Negative	B	Rectum liver	Chemotherapy¹	38	Dead
Poor	Positive	Negative	B	Rectum	APR	52	Alive
Poor	Negative	Positive	B	Rectum lung	Chemoradiotherapy¹	28	Dead
Moderate	Positive	Negative	B	Rectum	LAR	48	Alive
Moderate	Negative	Positive	B	Rectum liver	Chemotherapy¹	35	Dead
Well	Negative	Positive	B	Rectum	Colostomy¹	46	Dead

¹Palliative. Group A: Immediate conventional reoperation after transanal local excision; Group B: Transanal local excision alone. APR: Abdominoperineal resection; LAR: Low anterior resection.

Full Size Table

Citation: Wu ZY, Zhao G, Chen Z, Du JL, Wan J, Lin F, Peng L. Oncological outcomes of transanal local excision for high risk T₁ rectal cancers. World J Gastrointest Oncol 2012; 4(4): 84-88
URL: https://www.wjgnet.com/1948-5204/full/v4/i4/84.htm
DOI: https://dx.doi.org/10.4251/wjgo.v4.i4.84

Wu ZY, Zhao G, Chen Z, Du JL, Wan J, Lin F, Peng L. Oncological outcomes of transanal local excision for high risk T₁ rectal cancers. World J Gastrointest Oncol 2012; 4(4): 84-88 [PMID: 22532882 DOI: 10.4251/wjgo.v4.i4.84]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.